RxDoctor Payments Data

Tonya Dagda, APRN

Women's Health · Sebring, FLNPI 1912500406

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.

$1,708in general payments, 2019–2025

Across 87 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$235
  • Agile Therapeutics, Inc.$224
  • AbbVie$196
  • Exeltis, USA Inc.$157
  • Pfizer$118
  • Mayne Pharma Commercial LLC$111
  • plus $667 from 18 others

What the payments were for

  • Food & beverage$1,708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,708 in reported general payments places this provider in the 85th percentile of 308 women's health providers in Florida.

See all women's health providers in Florida

Medicare billing

Part B allowed, 2024
$11,501
Medicare patients
93
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol31$1,649
Clobetasol Propionate27$1,215
ValacyclovirValacyclovir Hcl11$639
Medroxyprogesterone Acetate11$392
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$301
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$139
Metronidazole18$85
Fluconazole15$43

Paid to pharmacies, not to this prescriber.

Other women's health in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →